Riferimento farmaci
Olaparib
Olaparib is a medicine in the class oncology. It is used for breast cancer.
- Classe del farmaco: Oncology
- Indicato per: breast cancer
Ultimo aggiornamento Fonti: US FDA label
Per operatori sanitari — solo a scopo di riferimento. Questa pagina è una sintesi breve, non è un parere medico e non sostituisce il RCP ufficiale né il giudizio clinico. Verificare sempre prima di prescrivere o dispensare.
Il contenuto clinico di questa pagina è disponibile solo in inglese.
In breve
- Classe del farmaco
- Oncology
- Codice ATC
- L01XK01
- Forme farmaceutiche comuni
- compressa
- Interazioni note
- 102 (Maggiore: 37 · Moderata: 60 · Minore: 5)
- Nomi commerciali
- 3
- Paesi e mercati
- 3
Per cosa si usa
Come agisce
Olaparib inhibits PARP enzymes (PARP1, PARP2, PARP3). Cytotoxicity may involve inhibition of PARP enzymatic activity and increased formation of PARP-DNA complexes, causing DNA damage and cancer cell death, with greater activity in cells deficient in BRCA1/2, ATM or other HRR genes.
Dose abituale nell'adulto (sintesi del foglio illustrativo)
All indications: 300 mg orally twice daily, with or without food; swallow tablets whole, do not chew, crush, dissolve or divide
Gravidanza e allattamento
- Gravidanza
- Unsafe No human data. Based on its mechanism (PARP inhibition) and rat studies showing malformations and embryo loss below human exposure, it can cause fetal harm. Avoid; confirm a negative pregnancy test, and use effective contraception during treatment and for 6 months after (EU: two methods).
- Allattamento
- Unsafe No data on milk levels or infant effects. Because of possible serious reactions in the infant, do not breastfeed during treatment and for 1 month after the last dose (US label); the EU label contraindicates breastfeeding.
Effetti indesiderati segnalati
- Nausea
- Fatigue
- Anemia
- Vomiting
- Diarrhea
- Decreased appetite
Chi deve prestare attenzione
- MDS/AML occurred in about 1.2% of patients, many fatal; monitor CBC at baseline and monthly; discontinue if confirmed.
- Pneumonitis occurred in 1.0%, including fatal cases; interrupt if suspected, discontinue if confirmed.
- Venous thromboembolism including fatal PE; VTE occurred in 8% of mCRPC patients; monitor and treat.
Informare il farmacista o il medico di gravidanza o allattamento, malattie renali o epatiche, allergie e di ogni altro farmaco o integratore assunto.
Interazioni principali (102)
- Amiodarone + Olaparib Major
- Amobarbital + Olaparib Major
- Apalutamide + Olaparib Major
- Aprepitant + Olaparib Major
- Azathioprine + Olaparib Major
- Carbamazepine + Olaparib Major
- Carboplatin + Olaparib Major
- Chloramphenicol + Olaparib Major
- Cisplatin + Olaparib Major
- Clarithromycin + Olaparib Major
Per gli utenti Pro+
Sblocca la pagina completa
Crei un account e avvii una prova di Pro+ per aprire la monografia completa di Olaparib: dosi, gravidanza e allattamento, effetti indesiderati, avvertenze e tutte le interazioni.
- Dosing by age, kidney and liver function, and further dose lines
- Renal and hepatic dose adjustments
- How to give it
- Pharmacokinetics
- Patient counselling points
- Food interactions
Provi Pro+ gratis per 14 giorni sul web. Nessuna carta.
Altri farmaci della stessa classe
Domande frequenti
What is Olaparib used for?
Olaparib is a medicine in the class oncology. It is used for Breast cancer, Ovarian cancer, Pancreatic cancer, Prostate cancer.
What side effects have been reported with Olaparib?
Nausea, Fatigue, Anemia, Vomiting, Diarrhea, Decreased appetite.
Can Olaparib be taken in pregnancy or while breastfeeding?
Pregnancy: Unsafe. No human data. Based on its mechanism (PARP inhibition) and rat studies showing malformations and embryo loss below human exposure, it can cause fetal harm. Avoid; confirm a negative pregnancy test, and use effective contraception during treatment and for 6 months after (EU: two methods). Breastfeeding: Unsafe. No data on milk levels or infant effects. Because of possible serious reactions in the infant, do not breastfeed during treatment and for 1 month after the last dose (US label); the EU label contraindicates breastfeeding.
What does Olaparib interact with?
MediHelp lists 102 known interactions for Olaparib. Major: 37 · Moderate: 60 · Minor: 5. The most serious include Amiodarone, Amobarbital, Apalutamide.
Monografie complete, posologie e verifica delle interazioni nell'app MediHelp
Apra il riferimento completo, verifichi le interazioni tra più farmaci e usi gli strumenti di posologia nell'app MediHelp.
